Robert Frank, MD
Otolaryngology · Hermitage, TNNPI 1750640512
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 155 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,123, 2.6 times the $438 reported in 2019.
Across 155 payments — averaging $27.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$550
- Regeneron Healthcare Solutions, Inc.$541
- Inspire Medical Systems, Inc.$477
- GSK$455
- Stryker$440
- Integra Lifesciences Corporation$314
- plus $2K from 15 others
What the payments were for
- Food & beverage$4,283100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 22 | $550 |
| Regeneron Healthcare Solutions, Inc. | 19 | $541 |
| Inspire Medical Systems, Inc. | 8 | $477 |
| GSK | 27 | $455 |
| Stryker | 14 | $440 |
| Integra Lifesciences Corporation | 4 | $314 |
| Genentech USA, Inc. | 16 | $292 |
| Aerin Medical Inc. | 2 | $238 |
| Acclarent, Inc | 3 | $209 |
| Novartis | 12 | $194 |
| Smith+Nephew | 2 | $108 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $87 |
| Kaleo, Inc. | 4 | $76 |
| AstraZeneca | 5 | $71 |
| Hikma Pharmaceuticals USA | 3 | $54 |
| Hologic Sales And Service, LLC | 3 | $49 |
| Optinose US, Inc. | 2 | $39 |
| Alk-abello, Inc | 2 | $39 |
| Baxter Healthcare | 1 | $19 |
| Olympus America Inc. | 1 | $16 |
| Neurent Medical Limited | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acclarent Aera$288
- Inspire$283
- Inspira Air$170
- RELIEVA SPINPLUS NAV$170
- TruDi Probe$170
- VIVAER STYLUS$158
- RHINAER STYLUS$158
- Acclarent Navwire$117
- XPRESS ENT DILATION SYSTEM$116
How this compares
$4,283 in reported general payments places this provider in the 80th percentile of 191 otolaryngology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 117 | $3,383 |
| Azelastine Hcl | 99 | $2,738 |
| Epinephrine | 13 | $1,968 |
| Fluticasone Propionate | 57 | $949 |
| Famotidine | 83 | $727 |
| Ofloxacin | 17 | $719 |
| Mometasone Furoate | 11 | $638 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 26 | $555 |
| Montelukast Sodium | 32 | $518 |
| Prednisone | 41 | $385 |
| Cefdinir | 19 | $378 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $307 |
| Doxycycline Hyclate | 20 | $190 |
| Omeprazole | 22 | $187 |
| Mupirocin | 22 | $183 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USAEpinephrine | $54 | $1,96813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 191 otolaryngology providers in Tennessee.
Other otolaryngology in Hermitage
- David FortuneHermitage$298K
- Grady BryantHermitage$74K
- Amit PatelHermitage$11K
- Justin MorganHermitage$6K
- Rakesh ChandraNashville$381K
- Marion GillespieMemphis$67K
- Clyde MathisonFarragut$66K
- Dean KlugGermantown$37K
- Michael TopfNashville$36K
- John GleysteenMemphis$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.